Skip to main content
. 2017 May 19;16:67. doi: 10.1186/s12933-017-0549-z

Fig. 6.

Fig. 6

Myocardial efficiency in type 2 diabetic patients at baseline and after 26-weeks of exenatide [dots; open dots (mean ± SD)] versus insulin glargine [squares; open squares (mean ± SD)]